Cite

HARVARD Citation

    Toumishey, E. et al. (2015). Final report of a phase 2 clinical trial of lenalidomide monotherapy for patients with T‐cell lymphoma. Cancer. 121 (5), pp. 716-723. [Online]. 
  
Back to record